In the short time since Januvia was released, health experts have linked the popular diabetes drug with serious conditions such as pancreatitis, thyroid cancer and pancreatic cancer.
Records also show that Merck, who makes Januvia, delayed important safety studies ordered by the FDA that may have revealed these risks to patients. Now, lawyers are helping those affected by thyroid or pancreatic cancer file a Januvia lawsuit for their damages.
Januvia helps control high blood sugar associated with diabetes by inhibiting the enzyme DPP-4 to increase the production of insulin. However, doing so may limit the body’s natural defense against cancer, since DPP-4 has been shown to prevent the spread of cancerous cells.
A recent study suggested diabetes drugs like Januvia could increase the risk of pancreatic cancer by 270% and thyroid cancer by 148%. With millions of patients taking this medication since 2006, experts fear that thousands could file a Januvia lawsuit.
Based on the volume of claims expected, cases are likely to begin in state courts before being consolidated in a central federal multi-district litigation court. A lawyer can explain the legal process and how to file a claim.
If you or a loved one have been diagnosed with pancreatic or thyroid cancer after taking Januvia, it is important to speak with a lawyer about the substantial compensation that may be available from a Januvia lawsuit. Contact us today.
Pancreatic cancer is a severe disease that attacks the lining of the pancreas. It is a leading cause of cancer death as it is often detected late and spreads quickly. While thyroid cancer is less severe, it can require surgery and ongoing treatment. If you have experienced the symptoms of either, you should speak with your doctor immediately.
The FDA first identified a link between Januvia and pancreatitis in 2009. In 2011, a study from UCLA found the drug could increase the risk of pancreatic cancer by 270% and the risk of thyroid cancer by 148%.
Although the FDA ordered Merck to conduct a new study over Januvia risks in 2009, records show the agency reprimanded the drug maker in 2012 for delaying the testing.
In February of 2013, the Journal for the American Medical Association published the latest study showing drugs like Januvia can double the risk of pancreatitis, which can lead to pancreatic cancer. Merck still has not added warnings for consumers about the cancer risks.
If you or a family member have been affected by pancreatic or thyroid cancer after taking Januvia, you should not face this disease alone simply because a large drug company failed to protect its patients. A lawyer can let you know what compensation may be available from a Januvia lawsuit, and how long you have to take action.
Due to the complexity of defective drug injury lawsuits, it is important to choose a lawyer with experience in this type of case. DrugRisk only recommends lawyers and law firms that have already handled diabetes drug cancer or Januvia lawsuits.
Contact us today for more information on the warnings, research, side effects and legal news related to Januvia and other diabetes drugs, or to speak with a lawyer. We are available 24 hours a day to help.